Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Irilliant Announces New Patent

Abstract:
Broad Claims Granted for Aerosol Synthesis of Nanomaterials

Irilliant Announces New Patent

Mountainview, CA | Posted on July 12th, 2010

Irilliant, Inc., a developer of high-throughput manufacturing processes for nanomaterials, has further enhanced and protected its CAFS (Chemical Aerosol-Flow Synthesis) process with a soon-to-be-issued U.S. patent.

The patent, "Controlled synthesis of nanoparticles using continuous liquid-flow aerosol method," will include claims for large-scale production of high-quality nanoparticles from aerosol. Earlier patented processes were not suitable for large-scale production, nor did they result in products of equally high quality.

In Irilliant's CAFS process, liquid containing the precursors for the synthesis flows continuously through a sprayer, which in turn generates micron-sized droplets. These droplets serve as microreactors, and facilitate the creation of narrow-size distributed nanoparticles. Spraying large amounts of liquid in the reactor, facilitates manufacture of high-quality, surface-stabilized nanoparticles in large quantities. Ultrasonic or large scale industrial sprayers can be used to further enhance throughput. This configuration permits production of a higher quality product with a greater yield compared to previous methods.

Nanomaterials are used in a variety of emerging technologies including next generation photovoltaics, electronic displays, and lighting. "To sustain the explosive growth in these arenas, reliable, high volume production of nanomaterials at the proper pricing points will be needed," said Stephanos Papademetriou, Irilliant's President and CEO. "This addition to our IP portfolio gives us a tremendous competitive advantage. It also moves us closer to our goal of becoming a global leader in the production of a diverse array of quality nanomaterials at price points that are orders of magnitude lower than any other method of nanomaterial synthesis."

####

About Irilliant
Irilliant, Inc. is a leading nanosynthesis manufacturing company. By utilizing the company's patented CAFS technology, Irilliant can manufacture large quantities of a variety of nearly monodisperse colloidal solutions of nanomaterials (including CdSe, CdTe, CdSe/ZnS, CdS Quantum Dots, nanometals, and nano-oxides) at extraordinarily low cost.

The company specializes in post processing of nanomaterials for further functionalization and adaptation into intelligent devices. Areas of expertise include modification of polymers with nanosilver for enhanced antimicrobial activity, fluorescently encoded and magnetically enhanced microparticles, high-density binary code fluorescent markers, ultra-high magnetization superparamagnetic nanomagnets, and quantum dot fiber structures.

For additional information, please visit www.Irilliant.com

For more information, please click here

Contacts:
Irilliant, Inc.
Marketing Department
67 East Evelyn Avenue
Suite 5
Mountain View, CA 94041
Email Contact
Tel: (650) 575-4450

Copyright © Marketwire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Information storage with a nanoscale twist: Discovery of a novel rotational force inside magnetic vortices makes it easier to design ultrahigh capacity disk drives March 28th, 2017

ATTOPSEMI Technology Joins FDXcelerator Program to Deliver Advanced Non-Volatile Memory IP to GLOBALFOUNDRIES 22 FDX Technology Platform: Leading-edge I-fuse brings higher reliability, smaller cell size and ease of programmability for consumer, automotive, and IoT applications March 27th, 2017

Leti and HORIBA Scientific to Host Webinar on Ultrafast Characterization Tool: Plasma Profiling Time-of-Flight Mass Spectrometer Tool Cuts Optimization Time In Layer Deposition and Fabrication of Wide Range of Applications March 27th, 2017

Laser activated gold pyramids could deliver drugs, DNA into cells without harm: Microstructures create temporary pores in cells March 27th, 2017

Materials/Metamaterials

Researchers make flexible glass for tiny medical devices: Glass can bend over and over again on a nanoscale March 27th, 2017

Argon is not the 'dope' for metallic hydrogen March 24th, 2017

Promising results obtained with a new electrocatalyst that reduces the need for platinum: Researchers from Aalto University have succeeded in manufacturing electrocatalysts used for storing electric energy with one-hundredth of the amount of platinum that is usually needed March 24th, 2017

Rice U. refines filters for greener natural gas: New study defines best materials for carbon capture, methane selectivity March 23rd, 2017

Announcements

Information storage with a nanoscale twist: Discovery of a novel rotational force inside magnetic vortices makes it easier to design ultrahigh capacity disk drives March 28th, 2017

ATTOPSEMI Technology Joins FDXcelerator Program to Deliver Advanced Non-Volatile Memory IP to GLOBALFOUNDRIES 22 FDX Technology Platform: Leading-edge I-fuse brings higher reliability, smaller cell size and ease of programmability for consumer, automotive, and IoT applications March 27th, 2017

Leti and HORIBA Scientific to Host Webinar on Ultrafast Characterization Tool: Plasma Profiling Time-of-Flight Mass Spectrometer Tool Cuts Optimization Time In Layer Deposition and Fabrication of Wide Range of Applications March 27th, 2017

Laser activated gold pyramids could deliver drugs, DNA into cells without harm: Microstructures create temporary pores in cells March 27th, 2017

Patents/IP/Tech Transfer/Licensing

Laser activated gold pyramids could deliver drugs, DNA into cells without harm: Microstructures create temporary pores in cells March 27th, 2017

Harris & Harris Group Issues Its Financial Statements as of December 31, 2016, Posts Its Annual Shareholder Letter, And Will Host a Conference Call for Shareholders on Friday, March 17, 2017 March 15th, 2017

Intertronics introduce new nanoparticle deagglomeration technology March 15th, 2017

Keystone Nano Announces The US FDA Has Awarded Orphan Drug Designation For Ceramides For The Treatment Of Liver Cancer November 8th, 2016

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project